The significant decrease in PCT levels following treatment in cancer patients, along with the correlation between elevated PCT and poor prognosis, indicates that the fundamental underlying mechanism may be explained by the tumor microenvironment [31,32,38,56]. The gene discussed is CALCA; the disease is cancer.